Human-derived cerebral organoids (COs) are an emerging model system for the study of human neural development and physiology. Here, we describe the assessment of metabolism in human-derived CO’s using high-resolution magic-angle spinning (HR-MAS) NMR spectroscopy. Metabolic changes during development are assessed by studying COs at various stages of maturity. Our results suggest that COs exhibit a metabolic profile similar to in vivo human brain metabolism, albeit with a few notable metabolic differences.
29 December 2025 in Progress in Biomedical Engineering
Parkinson’s disease (PD) is the second most common age-related neurodegenerative disorder after Alzheimer’s disease, affecting over ten million people worldwide. It is characterized by motor symptoms such as tremors, rigidity, and gait disturbances. Current treatments focus on alleviating symptoms and slowing down brain degeneration, but no cure exists, leading to a progressive decline in patients’ quality of life. Three-dimensional (3D) bioprinting has emerged as a powerful technique for developing constructs that engineer neural tissues with complexities mimicking physiological conditions. These constructs can serve as vehicles for controlled drug delivery and potential substitutes for neurodegeneration. This article aims to compile new research data and review the current state of PD models engineered by 3D bioprinting, focusing on the desired biochemical features of bioinks for cell protection during printing, cell behavior, and differentiation into 3D constructs. Additionally, it discusses the physical, mechanical, and chemical characterization of bioprinted scaffolds and the importance of post-printing assessment to ensure printability, shape fidelity, appropriate construct degradation, and extracellular matrix production rates for developing complex 3D bioprinted constructs. Finally, it proposes opportunities for models that can be used to study novel therapeutics and immunomodulatory responses in tissues engineered for PD and other neurodegenerative diseases.
Cell spheroids represent a scaffold-free route to form cell aggregates through maximizing cell-cell interactions. Spheroids have gained significant attention for the engineering of multilayer tissues as they offer a closer resemblance of physiological conditions observed in vivo, compared with traditional 2D models where cells are grown on flat surfaces. Multilayered tissues are formed by allowing spheroids to interact with themselves within relevant matrices mimicking native conditions of extracellular matrices. However, such conventional fusion methods provide little control over spheroid–spheroid interactions, making their reproducibility very limited. Additionally, such methods are lengthy, which is undesirable from the scalability and economic viewpoints. We propose a methodology to accelerate spheroid fusion by applying magnetic forces externally on spheroids previously magnetized by the internalization of iron oxide nanoparticles. A base mathematical model of spheroids assembly was implemented in COMSOL Multiphysics and involved a laminar two-phase field approach, which was validated by employing a novel segmentation algorithm. The magnetic effect was introduced by an applied volumetric magnetic force, which was generated by the action of two neodymium permanent magnets positioned perpendicular to the computational domain. Our simulations showed that magnetized spheroids fusion can be accelerated by about 55% after applying a magnetic force. In addition, we successfully tested a new modeling approach that allowed taking into account interactions between spheroids and the medium, as evidenced by a standard error of only 13% with respect to the experimental results shown in the literature. Importantly, these simulations also showed that the time required to fuse the spheroids is reduced by about 55%. We are currently validating the model experimentally on extracellular-matrix-derived hydrogels embedded with magnetized spheroids. Future work will be dedicated to calibrating the model with the collected experimental data.
Rheumatoid arthritis is an autoimmune disease that affects about 250,000 Colombians, 82% of whom are women. Current treatments include disease-modifying antirheumatic drugs (DMARDs), such as methotrexate (MTX), analgesics and physiotherapy. The most common DMARD is MTX, which binds to plasma proteins with low efficiency (50%) and has a half-life of 6 hours. Due to its limitations when administered orally, nanoparticles (NPs) have been proposed to overcome these limitations. NPs support the release of therapeutic molecules, minimizing side effects and increasing the bioavailability of the drug in a controlled administration. NPs synthesized from biodegradable polymers, such as polyglycolic lactic acid (PLGA), are convenient for drug delivery due to their high biocompatibility and ability to bind DMARDs such as MTX. PLGA NPs loaded with MTX (MTX-PLGA-NPs) have reduced the presence of proinflammatory factors such as IL-10 and TGF-β, suggesting their potential as anti-inflammatory therapies for arthritis. Therefore, this study aims to develop MTX-PLGA-NPs in bioactive and biocompatible hyaluronic acid-eucalyptus (GelHA-E) hydrogels to preserve their stability and delay their degradation. PLGA-NPs were synthesized with an average hydrodynamic diameter of 200 nm, the 1237 cm-1 band found in FITR indicated the successful covalent conjugation with MTX; the mass loss of only 1% in GelHA-E indicated the thermogravimetric stability of the biomaterial and the low hemolytic and platelet aggregation percentage confirmed the biocompatibility of the biomaterial as a potential localized, anti-inflammatory, and injectable treatment for rheumatoid arthritis.
There is an emerging interest in botanicals and plant extracts for medicinal practices due to their widely reported health benefits. Considering that a large variety of phytochemicals found in plants have been correlated with antioxidant and immunomodulatory properties, plant-derived products are promising candidates for modulating the progression and treatment of numerous